|
市場調查報告書
醫藥品市場的再度投入：擴大生產線與投入新市場戰略所確保之市場占有
Pharmaceutical Product Relaunch: Preserving Market Share through Line Extension and New Market Entry Strategies
|
本報告已在2011年12月09日停止出版。
為製藥產業提供創新且實用的調查與諮詢服務的美國專業市調公司 Cutting Edge Information （總公司：美國North Carolina），針對醫藥品市場的再度投入動向進行調查分析，並彙整出版了報告書 "Pharmaceutical Product Relaunch: Preserving Market Share through Line Extension and New Market Entry Strategies"。
此報告書含102張圖表共156頁，除了報告有關 再度投入醫藥品市場的目標、投資動向，也整理了再度投入的戰略與時機等情報。報告書之內容概要如下所示。
摘要
- 方法論與企業概況
- 再度投入醫藥品市場：成功的5項原則
再度投入戰略開發
透過生產線擴大再度投入
- 新調製方法與配送系統的開發
- 個案分析：品牌1
- 個案分析：品牌2
- 個案分析：品牌3
- 個案分析：品牌4
- 以新用藥方式的優勢與新用藥計畫投入市場
- 個案分析：品牌5
- 適用於小兒科的相關行銷
投入新市場
- 以新對策再度投入市場
- 個案分析：品牌6
- 個案分析：品牌7
- 併用療法
- 重新設定藥劑目的
- 個案分析：品牌8
- 個案分析：品牌9
再度投入市場的個案分析
圖表 封面圖片： 
Abstract
Product teams must begin their relaunch planning early to incorporate it into
a strong overall lifecycle management strategy. As product teams enter Phase 2
of development for their initial launch, they are often planning their
relaunch strategies for years later. Early planning is one of the key factors
in making a product relaunch successful.
Cutting Edge Information analyzed the relaunch strategies outlined in this
study into two categories: Line Extensions and New Market Entries. Each line
extension or new market entry strategy profiled in this study includes a
detailed analysis of:
- Implementation costs
- Time to implement
- Strategy outcome in terms of revenue
- Market share protection gained from implementing the tactic
Product relaunch success is a combination of timing, investment and the
science behind each drug. A drug manufacturer must first identify whether a
compound may be a viable relaunch candidate. Then, the manufacturer must
determine the level of investment necessary to bring a relaunch product to
market. The next, and perhaps most important, step is for the product team to
determine when to relaunch the drug.
Cutting Edge Information' s report, Pharmaceutical Product Relaunch: Preserving
Market Share through Line Extension and New Market Entry Strategies , includes
valuable benchmarks that will help you understand the science, investments and
timing behind common relaunch strategies.
Table of Contents
- Executive Summary
- Methodology and Profiled Companies
- Pharmaceutical Product Relaunch: Five Principles for Success
- Relaunch Strategy Development
- Line Extension Relaunches
- Case Study: Brand 1
- Case Study: Brand 2
- Case Study: Brand 3
- Developing New Formulations and Delivery Systems
- Case Study: Brand 4
- New Dosing Strength and New Dosing Regimen Launches
- Case Study: Brand 5
- Marketing Pediatric Indications
- New Market Entries
- New Indication Relaunches
- Case Study: Brand 6
- Case Study: Brand 7
- Combination Therapies
- Drug Repurposing
- Case Study: Brand 8
- Case Study: Brand 9
- Relaunch Case Studies
|
